119-HR-5355 Soccer Mom Impact Perspective

Summary of my opinion of the bill

As a family‑ and child‑safety‑focused voter, I support H.R. 5355. It commissions a GAO study on outcomes and cost‑effectiveness of adding direct/conjugated bilirubin to state newborn panels and directs HHS/HRSA to run a plain‑language education effort on early liver‑disease signs and the option/safety of living liver donation—without creating a new federal screening mandate or new appropriations for the education program. That’s a prudent, evidence‑first approach with immediate benefits for awareness and minimal near‑term costs. [1]Library of Congress — H.R.5355 — 119th Congress (2025–2026) — Text on Congress.…

• Why this matters for kids: Biliary atresia is rare but the leading reason infants need liver transplants; earlier detection lets more babies get the Kasai surgery sooner, improving transplant‑free survival. [5]NIDDK, NIH — Definition & Facts of Biliary Atresia[6]PubMed — Impact of early Kasai portoenterostomy on outcomes of biliary atresia:…
• Why this bill is measured: It studies real‑world effectiveness and value before states consider panel changes and uses existing funds for education, avoiding unfunded mandates. [1]Library of Congress — H.R.5355 — 119th Congress (2025–2026) — Text on Congress.…
• Equity upside: Infants have the highest pre‑transplant mortality; better, earlier detection plus accurate information on living donation can narrow gaps—especially for rural and Medicaid‑covered families—if paired with access to specialty care. [3]HRSA/SRTR — SRTR Annual Data Report 2022 – Liver (Pediatric sections)

Specific impacts and my judgment of each

Economic impact on households, small businesses, and state systems

• Household medical risk and costs (good): If screening proves effective, more infants reach surgery sooner; US data show DB/conjugated bilirubin screening detected all known biliary‑atresia cases in pilots and shifted surgery ~19 days earlier—changes linked to better short‑term outcomes and higher transplant‑free survival when the Kasai occurs earlier. Earlier treatment can avert prolonged ICU stays and some transplants, lowering lifetime costs for families. [2]JAMA Network — Diagnostic Yield of Newborn Screening for Biliary Atresia Using…[6]PubMed — Impact of early Kasai portoenterostomy on outcomes of biliary atresia:…
• Insurance coverage trajectory (neutral to good): Because the bill does not add a condition to the federal RUSP list, it doesn’t trigger ACA preventive‑services coverage now. If, in the future, evidence led to RUSP adoption, most plans would cover such screening without cost‑sharing; until then, the GAO study helps states avoid costly missteps. [4]HRSA — Recommended Uniform Screening Panel (RUSP) overview
• State labs and hospitals (good if phased): The bill orders a GAO cost‑effectiveness analysis rather than mandating immediate adoption, giving state newborn‑screening programs time to plan staffing, quality control, and referral pathways before incurring new costs. [1]Library of Congress — H.R.5355 — 119th Congress (2025–2026) — Text on Congress.…
• Federal budget (neutral): The public‑education program uses existing HHS resources—no new authorizations—so near‑term federal outlays are limited. [1]Library of Congress — H.R.5355 — 119th Congress (2025–2026) — Text on Congress.…

Social impact on communities and vulnerable populations

• Highest‑risk infants (good): Infants under 1 year have the highest pre‑transplant mortality; earlier detection plus clear referral instructions for primary‑care providers can reduce late presentations. [3]HRSA/SRTR — SRTR Annual Data Report 2022 – Liver (Pediatric sections)
• Equity and access (good with caveats): National transplant data show persistent disparities by age and other factors; pairing screening/education with streamlined access to pediatric hepatology and transplant centers is essential so rural and low‑income families benefit equally. [3]HRSA/SRTR — SRTR Annual Data Report 2022 – Liver (Pediatric sections)
• Living donation information (good): Modern US data show pediatric living‑donor liver transplants achieve equal or better graft and patient survival than deceased‑donor grafts; accurate education can expand options for families while emphasizing donor safety. [7]HRSA/SRTR — SRTR 2022 outcomes: Living‑donor vs deceased‑donor pediatric liver…

Environmental impact and sustainability

• Minimal direct environmental effects (neutral): The bill centers on analysis and education, not large‑scale procurement or construction. Any future screening expansion would add marginal lab throughput and biohazard waste but is negligible relative to hospital baselines. (No citation needed.)

Long‑term vs. short‑term effects

• Short‑term (good): Immediate benefits are caregiver awareness and clearer provider guidance, with negligible federal cost. [1]Library of Congress — H.R.5355 — 119th Congress (2025–2026) — Text on Congress.…
• Long‑term (potentially very good): If GAO finds DB screening cost‑effective and states adopt it with good follow‑up pathways, we should see earlier surgeries and possibly fewer infant deaths or transplants over time. Pilot data show 100% detection in known cases and improved timing; SRTR trends show infants carry the highest risk today, leaving room for gains. [2]JAMA Network — Diagnostic Yield of Newborn Screening for Biliary Atresia Using…[3]HRSA/SRTR — SRTR Annual Data Report 2022 – Liver (Pediatric sections)

Unintended consequences to manage

• False positives and caregiver anxiety (manageable): JAMA pilots had high specificity but low PPV (5.9%), meaning most positives won’t be biliary atresia; recent implementation work found a net false‑positive rate around 0.3% when retesting at two weeks. Clear follow‑up algorithms and communication guardrails are essential. [2]JAMA Network — Diagnostic Yield of Newborn Screening for Biliary Atresia Using…[8]SAGE Journals — Implementation study of newborn DB screening and false‑positive…
• Specialist capacity (manageable): More early referrals can briefly strain pediatric hepatology clinics; the GAO report should quantify workforce needs so states can scale appropriately. [1]Library of Congress — H.R.5355 — 119th Congress (2025–2026) — Text on Congress.…
• Messaging on living donation (guardrails needed): Education should pair benefits with donor‑safety standards; while pediatric outcomes are excellent with living donors, programs must maintain rigorous donor protections and informed consent. [7]HRSA/SRTR — SRTR 2022 outcomes: Living‑donor vs deceased‑donor pediatric liver…

Sources for metrics: NIDDK (incidence); JAMA newborn DB screening study (diagnostic yield); SRTR 2022 Annual Report (mortality and survival). [5]NIDDK, NIH — Definition & Facts of Biliary Atresia[2]JAMA Network — Diagnostic Yield of Newborn Screening for Biliary Atresia Using…[3]HRSA/SRTR — SRTR Annual Data Report 2022 – Liver (Pediatric sections)

Overall stance